EGFR and central nervous system cancer: Pharmacological blockade of the EGFR by gefetinib had a rather modest inhibitory effect on glioma cell proliferation whereas pharmacological inhibition of SphK1 strongly blocked proliferation and induced apoptosis of a GBM-derived neurosphere cell line (Estrada-Bernal et al., 2011).